Understanding COVID-19 vaccine efficacy
- 13 November 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6518), 763-765
- https://doi.org/10.1126/science.abe5938
Abstract
Vaccine efficacy in high-risk groups and reduced viral shedding are important for protectionThis publication has 12 references indexed in Scilit:
- Vaccine optimization for COVID-19, who to vaccinate first?Published by Cold Spring Harbor Laboratory ,2020
- Ethics of controlled human infection to address COVID-19Science, 2020
- Temporal Confounding in the Test-Negative DesignAmerican Journal of Epidemiology, 2020
- The Use of Test-negative Controls to Monitor Vaccine EffectivenessEpidemiology, 2020
- Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studiesInternational Journal of Epidemiology, 2016
- Influenza Vaccine Prevents Medically Attended Influenza-Associated Acute Respiratory Illness in Adults Aged ≥50 YearsThe Journal of Infectious Diseases, 2014
- Design and Analysis of Vaccine StudiesPublished by Springer Science and Business Media LLC ,2010
- Optimizing the Dose of Pre-Pandemic Influenza Vaccines to Reduce the Infection Attack RatePLoS Medicine, 2007
- Estimating Vaccine Efficacy From Secondary Attack RatesJournal of the American Statistical Association, 2003
- Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trialThe Lancet, 2000